18 /100
LOW RISK
Score updated Jul 14, 2026

PACS — PACS Group, Inc. Dilution Risk Tracker

Track PACS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PACS — Get alerts when the score changes →

As of July 14, 2026, PACS Group, Inc. (PACS) has a DilutionWatch DilutionScore of 18/100, rated LOW dilution risk. PACS Group, Inc. has a market capitalization of $5.80B, 158.27M shares outstanding, 221 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
60
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for PACS.
🔔 Track PACS — Get forecast alerts →

💹 Market Data

Market Cap$5.80B
Shares Outstanding158.27M
Float47.31M
Cash$247.98M
Debt$248.20M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 9.2% shares (2026Q1 vs prior)
221 institutional holders · 52.10M shares
#1 COHEN & STEERS, INC. 9.12M shares
#2 FMR LLC 5.25M shares
#3 BlackRock, Inc. 3.78M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest4.53M
Days to Cover4.2
% of Float9.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

3 FORM3 Apr 27, 2026
4 INSIDER TRANSACTION Mar 09, 2026
4 INSIDER TRANSACTION Mar 05, 2026
3 FORM3 Mar 05, 2026
4 INSIDER TRANSACTION Mar 03, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for PACS Shareholders

PACS Group, Inc. (PACS) has a DilutionScore of 18/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for PACS shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for PACS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for PACS alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track PACS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PACS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for PACS
📊 PACS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PACS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.